ArticleWorld journal of hepatology2017

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.

Satoshi Yamagiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.